ArticleOsteoarthritis imaging2026
Disruption of the microenvironmental ecosystem in subchondral bone marrow lesions: Roles in osteoarthritis pathophysiology, pain and progression.
Article in Osteoarthritis imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Editorial: Special issue imaging and pain.Osteoarthritis imaging · 2026Article
- Current status and influencing factors of early delayed neurocognitive recovery in older adult patients after major orthopedic surgery under general anesthesia: a cohort study.Frontiers in public health · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This narrative review explores the role of subchondral bone in the pathophysiology of osteoarthritis (OA), emphasizing the biomechanical and biochemical contributions that it makes to disease progression. A fresh perspective is presented by the authors in the form of a novel hypothesis that implicates mechano-inflammatory disruption of the bone marrow (BM) microenvironmental ecosystem (BM niche), unresolved inflammation, and fibrosis as key drivers of OA pathogenesis and pain. BMLs, detectable via magnetic resonance imaging (MRI), serve as dynamic imaging biomarkers that correlate with pain severity and structural deterioration, making them valuable in patient stratification for enhanced clinical trials and more effective therapeutic monitoring. Persistent inflammation within the BM microenvironmental niche exacerbates nociceptive signaling and structural joint damage. The parallels between OA, hematopoietic malignancies and immunological disorders of the BM underscore the potential for targeting inflammatory and fibrotic pathways within the BM niche as novel therapeutic strategies. Additionally, obesity-associated BM dysfunction raises the prospect of weight-loss interventions, including GLP-1 receptor agonists, as potential disease-modifying approaches for OA. We propose that the future research agenda should focus on integrating imaging biomarkers with genomic, molecular and clinical data to explore alterations in the BM microenvironmental ecosystem. This new knowledge may refine precision medicine strategies, improve early detection, enhance prognostic monitoring and develop targeted therapies aimed at successful modification of OA progression and effective control of pain mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.